Introduction
Ischemic stroke remains a major cause of mortality in Japan (1) . Age, atrial fibrillation (AF) and stroke severity are the most powerful predictors of early death for patients with acute ischemic stroke (2) (3) (4) (5) . Furthermore, other involved factors such as female gender (5, 6) , diabetes (3) , hyperglycemia (7, 8) , previous stroke (3) , congestive heart failure (7) , ischemic heart disease (5) , smoking (5) , high and low blood pressure on admission (9) , and high uric acid level (10) have also been reported previously.
Brain natriuretic peptide (BNP) is a 32-amino acid polypeptide containing a 17-amino acid ring structure that was isolated from porcine brain in 1988 and which is a diuretic factor with vasodilator activity (11) . BNP is primarily released from ventricular myocardium. Recently, BNP was reported to be useful in the assessment of patients with congestive heart failure (12) . In addition, plasma BNP levels have also been shown to be elevated in patients with acute ischemic stroke, in particular those with atrial fibrillation (AF) (13, 14) . A recent study demonstrated that the plasma level of BNP is an independent predictor of long-term mortality after stroke (15) .
The present study investigated whether the plasma BNP level on admission in ischemic stroke patients could serve as a useful marker of in-hospital death. (Fig. 1) .
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Discussion
In the acute ischemic stroke patients in this study, the mean plasma BNP level on admission was significantly higher in the deceased group than in the survival group. A plasma BNP level of >240 pg/mL in these acute ischemic stroke patients was an independent predictor of in-hospital death. Furthermore, the mortality rate was 15 (18) . Therefore, heart failure could induce enlargement of infarction size, and development of brain edema. Thus, the plasma BNP, being a marker of congestive heart failure, might be elevated in the deceased group. Second, in-hospital death patients have already suffered a congestive heart failure prior to stroke onset, and congestive heart failure is known to be associated with an increased risk of death during hospitalization (7) . Therefore, the plasma BNP level would be elevated in the deceased group of patients. Third, neuroendocrine changes due to stroke introduce an increased load on the cardiac ventricles, and patients with underlying cardiac disease may develop congestive heart failure. In the present study, AF was more prevalent in the deceased group than in the survival group. Congestive heart failure is well known to frequently complicate ischemic stroke in patients with AF. Therefore, we suspected that plasma BNP levels would be elevated in patients in the deceased group.
Little is known regarding the association between hemo- (19) , hypertrophic cardiomyopathy (20) , dialysis-dependent chronic renal failure (21) , pulmonary embolism (22) , and Takotsubo cardiomyopathy (23 
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